DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Our health economics team has developed cost-effectiveness and budget impact models for many of the world's leading pharmaceutical and medical device companies. 

Our expert team of experienced, in-house health economic modelers are adept at developing a wide range of economic tools, including decision-tree models, Markov models, patient-level simulations and highly efficient functionality for full deterministic and probabilistic sensitivity analyses.

 

Key health economic services include:

  • Global economic modelling & country adaptations
  • Cost-effectiveness/ cost minimization analysis
  • Budget impact modelling
  • Health economic strategy & onsite training publications